Lialda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Fenofibrate in Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Fenofibrate 160mg Sponsors:   Tanta University;   Eman Ibrahim Elberri, Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University;   Hend El-Said Abo Mansour, Biochemistry Department, Faculty of Pharmacy, Menoufia University;   Monir Hussein Bahgat, Internal Medicine Department (Gastroenterology and Hepatology) , Faculty of Medicine, Mansura University;   Eman Maamoun Ali El-Khateeb, Lecturer of Clinical Pharmacy, Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2023 Category: Research Source Type: clinical trials

Fenofibrate in Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Fenofibrate 160mg Sponsors:   Tanta University;   Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University;   Hend El-Said Abo Mansour, Faculty of Pharmacy, Menoufia University;   Monir Hussein Bahgat, Faculty of Medicine, Mansura University;   Eman Maamoun Ali El-Khateeb, Lecturer of Clinical Pharmacy, Faculty of Ph armacy, Tanta University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2023 Category: Research Source Type: clinical trials

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
Conditions:   Immune-related Adverse Event;   Diarrhea;   Advanced Melanoma;   Advanced Rectal Carcinoma Intervention:   Drug: Mesalamine Sponsor:   AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2022 Category: Research Source Type: clinical trials